Document Type : Case Report
Authors
- Farid Qoorchi Moheb Seraj 1
- Sajad Ataei Azimi 1
- Kamran Roudini 2
- Zahra Rezaieyazdi 3
- Seyed Ali Ebrahimy 4
1 Department of Hematology and Oncology, Faculty of medicine, Mashhad university of medical sciences, Mashhad, Iran
2 Department of Internal medicine, Cancer institute, Imam Khomeini Hospital, Tehran university of medical sciences, Tehran, Iran
3 Rheumatic Diseases Research Center, Mashhad University of Medical Sciences
4 Student Research committee, Islamic azad university, Mashhad, Iran.
Abstract
Felty syndrome is a form of rheumatoid arthritis (RA) that usually presents with neutropenia and splenomegaly. It usually occurs in the setting of long-lasting (RA)and rarely as an early manifestation of RA. Case presentation: A 47-year-old female patient presented to the emergency department with a history of fever and arthralgia. She was found to have splenomegaly and pancytopenia. After ruling out hematologic malignancies by bone marrow biopsies, she was diagnosed with RA. Rheumatoid factor (RF) and cyclic citrullinated peptide antibody (Anti-CCP) levels were elevated. The patient was ultimately diagnosed with early-onset Felty syndrome in the course of RAand an occult hepatitis B infection. Despite the low incidence rate of Felty syndrome, it should be considered as a differential diagnosis of patients with arthralgia, fever, neutropenia, and splenomegaly.
Keywords
Main Subjects
- Owlia MB, Newman K, Akhtari M. Felty's Syndrome,Insights and Updates. Open Rheumatol J 2014; 8:129-36. doi: 10.2174/1874312901408010129.
- Gupta A, Abrahimi A, Patel A. Felty syndrome: a casereport. J Med Case Rep 2021; 15(1):273. doi:10.1186/s13256-021-02802-9.
- Balint GP, Balint PV. Felty's syndrome. Best Pract Res
Clin Rheumatol 2004; 18(5):631-45. doi:10.1016/j.berh.2004.05.002.
- Thorne C, Urowitz MB. Long-term outcome in Felty'ssyndrome. Ann Rheum Dis 1982; 41(5):486-9. doi:
10.1136/ard.41.5.486.
- Xiao RZ, Xiong MJ, Long ZJ, Fan RF, Lin DJ.Diagnosis of Felty's syndrome, distinguished from
hematological neoplasm: A case report. OncolLett2014; 7(3):713-16. doi: 10.3892/ol.2013.1779.
- Patel R, Akhondi H. Felty Syndrome. In: StatPearls[Internet]. StatPearls Publishing; 2021.
- Barilà G, Calabretto G, Teramo A, Vicenzetto C,Gasparini VR, Semenzato G. et al. T cell large granularlymphocyte leukemia and chronic NK lymphocytosis.Best Pract Res Clin Haematol 2019; 32(3):207-16. doi:10.1016/j.beha.2019.06.006.
- Osuji N, Matutes E, Catovsky D, Lampert I,Wotherspoon A. Histopathology of the spleen in T-celllarge granular lymphocyte leukemia and T-cellprolymphocytic leukemia: a comparative review. Am JSurg Pathol 2005; 29(7):935-41. doi: 10.1097/01.pas.0000160732.43909.3f. l
- Calabretto G, Teramo A, Barilà G, Vicenzetto C,Gasparini VR, Semenzato G. et al. Neutropenia
and Large Granular Lymphocyte Leukemia: FromPathogenesis to Therapeutic Options. Cells 2021;10(10). doi:10.3390/cells10102800.
- Savola P, Brück O, Olson T, Kelkka T, Kauppi MJ,Kovanen PE. et al. Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia. Haematologica 2018; 103(2):304-12. doi:
10.3324/haematol.2017.175729.
- Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. Jama 2018; 320(13):1360-72. doi: 10.1001/jama.2018.13103.
- Chavalitdhamrong D, Molovic-Kokovic A, Iliev A.Felty's syndrome as an initial presentation of
rheumatoid arthritis: a case report. Cases J 2009; 2:206.doi: 10.1186/1757-1626-2-206.
- Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol 2016; 22(39):8720-34. doi: 10.3748/wjg.v22.i39.8720.
- de Almeida NAA, de Paula VS. Occult Hepatitis B virus
(HBV) infection and challenges for hepatitis elimination: A literature review. J Appl Microbiol 2022; 132(3):1616-35. doi: 10.1111/jam.15351.
- Hedayati-Moghaddam MR, Soltanian H, Behzadifar MJHm. Occult hepatitis B virus infection prevalenceamong different populations of iran: A systematicreview and meta-analysis. 2020; 20(6). Journal Article.
- Yip TC, Wong GL. Current Knowledge of Occult Hepatitis B Infection and Clinical Implications. SeminLiver Dis 2019; 39(2):249-60. doi: 10.1055/s-0039- 1678728.
- Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martín L, Prieto M. et al. Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based
regimens to treat hematologic malignancies: The Preblin study. PLoS One 2017; 12(9):e0184550. doi: 10.1371/journal.pone.0184550.
- Shi M, He R, Feldman AL, Viswanatha DS, Jevremovic D, Chen D. et al. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia. Hum Pathol 2018; 73:74-81. doi: 10.1016/j.humpath.2017.12.014.
)